Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats

European Journal of Pharmacology

Volumn 561, Issue 1-3, 2007, Pages 144-150

  Dharmani, Murugan ^a   Mustafa, Mohd Rais ^a   Achike, Francis I ^b   Sim, Meng Kwoon ^c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Angiotensin 1 7; Angiotensin II; Diabetic rat; Isolated perfused kidney; Mesenterial arterial bed

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7] RECEPTOR ANTAGONIST; DEXTRO ALANINE; DEXTRO ALANINE 7 ANGIOTENSIN 1; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; HYPERTENSION; KIDNEY BLOOD VESSEL; MALE; MESENTERY BLOOD VESSEL; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES; VASOCONSTRICTION;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; KIDNEY; MALE; NITRIC OXIDE; PEPTIDE FRAGMENTS; PROSTAGLANDINS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ANGIOTENSIN; RENAL CIRCULATION; SPLANCHNIC CIRCULATION; STREPTOZOCIN;

EID: 33947195336     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.037     Document Type: Article

References (39)

1. Ambuhl P., Felix D., and Khosla M.C. [7-D-ALA]-angiotensin 1-7: selective antagonism of Angiotensin-(1-7) in the rat paraventricular nucleus. Brain Res. Bull. 35 (1994) 289-291
2. Ardaillou R., and Chansel D. Synthesis and effects of active fragments of angiotesin II. Kidney Int. 52 (1997) 1458-1468
3. Broshinan K.B. Effect of angiotensin-(1-7) on nitric oxide release. Am. J. Cardiol. 82 (1998) 17S-19S
4. Chappell M.C., Iyer S.N., Diz D.I., and Ferrario C.M. Antihypertensive effects of angiotensin-(1-7). Braz. J. Med. Biol. Res. 31 (1998) 1205-1212
5. Clark M.A., Diz D.I., and Tallant E.A. Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells. Hypertension 37 (2001) 1141-1146
6. 1A receptor by pharmacologic concentrations of angiotensin-(1-7). J. Cardiovasc. Pharmacol. 37 (2001) 437-448
7. Clark M.A., Tallant E.A., Tommasi E., Bosch S., and Diz D.I. Angiotensin-(1-7) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism. J. Cardiovasc. Pharmacol. 41 (2003) 276-283
8. Dharmani M., Mustafa M.R., Achike F.I., and Sim M.K. Effect of des-Asp-angiotensin I on the actions of angiotensin II in the isolated renal and mesenteric vasculature of hypertensive and STZ-induced diabetic rats. Regul. Pept. 129 (2005) 213-219
9. Freeman E.J., Chilsolm G.M., Ferrario C.M., and Tallant E.A. Angiotensin-(1-7) inhibits vascular smooth muscle growth. Hypertension 28 (1996) 104-108
10. Ferrario C.M. Angiotensin-(1-7) and hypertensive mechanisms. J. Nephrol. 11 (1998) 278-283
11. Ferrario C.M., Brosnihan K.B., Diz D.I., Jaiswal N., Khosla M.C., Milsted A., and Tallant E.A. Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension 18 (1991) 126-133
12. Ferrario C.M., Chappell M.C., Tallant E.A., Broshinan K.B., and Diz D.I. Counter-regulatory actions of angiotensin-(1-7). Hypertension 30 (1997) 535-541
13. Fujii K., Soma M., Huang Y.S., Manku M.S., and Horrobin D.F. Increased release of prostaglandins from the mesenteric vascular bed of diabetic animals: the effects of glucose and insulin. Prostaglandins Leukot. Med. 24 (1986) 151-161
14. Fujii K., Horrobin D.F., and Huang Y.S. Effect of dietary cholesterol on the release of prostacylin from mesenteric vascular bed in diabetic rat. Diabetes Metab. 13 (1987) 87-91
15. Gironacci M.M., Coba M.P., and Pena C. Angiotensin-(1-7) binds at the type 1 angiotensin II receptors in rat renal cortex. Regul. Pept. 84 (1999) 51-54
16. Hsiao H.Y., Mak O.T., Yang C.S., Liu Y.P., Fang K.M., and Tzeng S.F. TNF-α /IFN-γ-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling. Glia 55 (2007) 214-223
17. Ichiki T., Usui M., Kato M., Funakoshi Y., Ito K., Egashira K., and Takeshita A. Downregulation of angiotensin II type 1 gene transcription by nitric oxide. Hypertension 31 (1998) 342-348
18. Jaiswal N., Tallant E.A., Jaiswal E.K., Diz D.I., and Ferrario C.M. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine smooth muscle cells: subtypes of angiotensin receptors involved. J. Pharmacol. Exp. Ther. 265 (1993) 664-673 (May)
19. Kost Jr. C.K., Li P., Williams D.S., and Jackson E.K. Renal vascular responses to angiotensin II in conscious spontaneously hypertensive and normotensive rats. J. Cardiovasc. Pharmacol. 31 (1998) 854-861
20. Kostenis E., Milligan G., Christopoulos A., Sanchez-Ferrer C.F., Heringer-Walther S., Sexton P.M., Gembardt F., Kellett E., Martini L., Vanderheyden P., Schultheiss H.P., and Walther T. G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111 (2005) 1806-1813
21. Kucharewicz I., Pawlak R., Matys T., Chabielska E., and Buczko W. Angiotensin-(1-7): an active member of the renin-angiotensin system. J. Physiol. Pharmacol. 53 4 (2002) 533-540
22. Le Tran Y., and Forster C. Angiotensin-(1-7) and the rat aorta: modulation by the endothelium. J. Cardiovasc. Pharmacol. 30 (1997) 676-682
23. Loot A.E., van Biuten A., Roks A.J., and Henning R.H. The suitability of iodinated angiotensin-(1-7) peptides as pharmacological tools. J. Pharmacol. Toxicol. Methods 51 (2005) 51-55
24. Mohan J.M., Carr R.D., Nicol A.K., and Henderson I.W. Angiotensin-(1-7) is an antagonist at the type 1 angiotensin II receptor. J. Hypertens. 12 (1994) 1377-1381
25. Oliveira M.A., Fortes Z.B., Santos R.A.S., Khosla M.C., and De Carvalho M.H. Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo. Peptides 20 (1999) 1195-1201
26. Roks A.J., van Geel P.P., Pinto Y.M., Biukema H., Henning R.H., de Zeeuw D., and van Gilst W.H. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension 34 (1999) 296-301
27. Santos R.A.S., Compagnole-Santos M.J., Baracho N.C., Fontes M.A., Silva L.C., Neves L.A., Oliveira D.R., Caligiorne S.M., Rodrigues A.R., Gropen Junior C., Carvalho W.S., Simoes e Silva A.C., and Khosla M.C. Characterization of a new angiotensin antagonist selective for angiotensin 1-7: evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res. Bull. 35 (1994) 293-298
28. Santos R.A.S., Campagole-Santos M.J., and Andrade S.P. Angiotensin-(1-7): an update. Regul. Pept. 91 (2000) 45-62
29. Santos R.A.S., Passaglio K.T., Pesquero J.B., Bader M., and Simoes de Silva A.C. Interactions between angiotensin-(1-7), kinins and angiotensin II in kidney and blood vessels. Hypertension 38 (2001) 660-664
30. Santos R.A.S., Simoes de Silva A.C., Maric C., Silva D.M., Machado R.P., de Buhr I., Heringer W.S., Lopes M.T., Bader M., Mendes E.P., Lemos V.S., Campagnole-Santos M.J., Schultheiss H.P., Speth R., and Walther T. Angiotensin-(1-7) is an endogenous ligand for the G-protein coupled receptor Mas. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8258-8263
31. Stegbauer J., Oberhauser V., Vonend O., and Rump L.C. Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats. Cardiovasc. Res. 61 (2004) 352-359
32. Stegbauer J., Vonend O., Oberhauser V., Sellin V., and Rump L.C. Angiotensin II receptor modulation of renal vascular resistance and neurotransmission in young and adult spontaneously hypertensive rats. Kidney Blood Press. Res 28 (2005) 20-26
33. Sugaitno E., Samsudi A.R., Ibrahim M.F., and Sosroseno W. The effect of nitric oxide on the production of prostaglandin E2 by hydroxypatite-stimulated a human oesteoblast (HOS) cell line. Biomed. Pharmacother. 60 (2006) 147-151
34. Tallant E.A., Lu X., Weiss R.B., Chappell M.C., and Ferrario C.M. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 29 (1997) 388-393
35. Ueda S., Masumori-Maemoto S., Ashino K., Nagahara T., Gotoh E., Umemura S., and Ishii M. Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man. Hypertension 35 (2000) 998-1001
36. Vallon V., Heyne N., Richter K., Khosla M.C., and Fechter K. [7-D-ALA]-angiotensin 1-7 blocks renal actions of angiotensin-(1-7) in the anaesthetized rat. J. Cardiovasc. Pharmacol. 32 (1998) 164-167
37. van der Wouden E., Ochodnicky P., Dokkum R.P.E., Roks A., Deelman L., Zeeuw D., and Henning R.H. The role of angiotensin 1-7 in renal vasculature of the rat. J. Hypertens. 24 (2006) 1971-1978
38. Widdop R.E., Sampey D.B., and Jarrott B. Cardiovascular effect of angiotensin 1-7 in conscious spontaneously hypertensive rats. Hypertension 34 (1999) 964-968
39. Zhu Z., Zhong J., Zhu S., Liu D., Van Der Giet M., and Tepel M. Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction. J. Cardiovasc. Pharmacol. 40 (2002) 693-700